Benzodiazepines in autism spectrum disorder—wise or otherwise?
- 3 May 2021
- journal article
- letter
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 27 (5), 552
- https://doi.org/10.1017/s1092852921000481
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical reviewCNS Spectrums, 2020
- Antineuroinflammatory therapy: potential treatment for autism spectrum disorder by inhibiting glial activation and restoring synaptic functionCNS Spectrums, 2019
- Restricted and repetitive behaviours in autism spectrum disorder through a clinical lens!Asian Journal of Psychiatry, 2018
- A roadmap to clinical assessment and evaluation of autism spectrum disorderJournal of Family Medicine and Primary Care, 2017
- The GABAA Receptor as a Therapeutic Target for Neurodevelopmental DisordersNeuron, 2015